newsfilter
← Latest News
PR Newswire·

OncoHost's PROphet® Platform to Support Henlius US-Based Phase III Trial for Patients with Extensive-Stage Small Cell Lung Cancer

Proteomic Pattern Recognition Technology to Help Identify and Characterize Potential Resistance Patterns in Recruited Patients, Provide Correlative Biomarkers to Guide Outcomes